Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-06

Clinical Trial Update: Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty [Phase 4]

View source ↗

Summary

Phase 4 trial evaluates the efficacy and safety of FLOSEAL gelatin-thrombin matrix for hemostasis in total knee arthroplasty. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Floseal

Snippet

Sponsor: Baxter Healthcare Corporation | Conditions: Knee Replacement Surgery, Osteoarthritis | Phase 4 | Status: COMPLETED | Results posted: 2014-06-06